We previously found that SELENOP expression is regulated via an AMPK–FoxOs axis, and metformin, a drug widely used for the treatment of type 2 diabetes, suppresses SeP expression via an AMPK–FoxO3a pathway18, 43, 44. Here, SELENOP is linked to type 2 diabetes mellitus.